Clinical Trial Update: Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing Micropulse 577nm laser with traditional laser treatment for central serous chorioretinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Choroidopathy

Drugs mentioned

• Micropulse 577nm Laser
• Traditional laser treatment

Snippet

Sponsor: The Eye Hospital of Wenzhou Medical University | Conditions: Central Serous Choroidopathy | Phase 2, Phase 3 | Status: COMPLETED